These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8131365)

  • 21. Synthetic or natural surfactants.
    Halliday HL
    Acta Paediatr; 1997 Mar; 86(3):233-7. PubMed ID: 9099309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lucinactant for the treatment of respiratory distress syndrome in neonates.
    Piehl E; Fernandez-Bustamante A
    Drugs Today (Barc); 2012 Sep; 48(9):587-93. PubMed ID: 23032799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of surfactant replacement trials.
    Suresh GK; Soll RF
    J Perinatol; 2005 May; 25 Suppl 2():S40-4. PubMed ID: 15861172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of surfactant in pulmonary disorders in full-term infants.
    Sun B
    Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary haemorrhage in infants with gestational age of less than 30 weeks.
    De Carolis MP; Romagnoli C; Cafforio C; Piersigilli F; Papacci P; Vento G; Tortorolo G
    Eur J Pediatr; 1998 Dec; 157(12):1037-8. PubMed ID: 9877052
    [No Abstract]   [Full Text] [Related]  

  • 27. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
    N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lucinactant for the prevention of respiratory distress syndrome in premature infants.
    Jordan BK; Donn SM
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):115-21. PubMed ID: 23473590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Lindemann R; Grøgaard J
    Tidsskr Nor Laegeforen; 1991 Mar; 111(8):1032-3. PubMed ID: 2042202
    [No Abstract]   [Full Text] [Related]  

  • 30. Exogenous surfactant use in neonates.
    Ishisaka DY
    Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory distress syndrome and intracranial hemorrhage: cause or association? Inferences from surfactant clinical trials.
    Leviton A; VanMarter L; Kuban KC
    Pediatrics; 1989 Nov; 84(5):915-22. PubMed ID: 2677963
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome.
    Morley CJ
    Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surfactant therapy of premature infants. Complications and mortality are reduced].
    Hjalmarson O
    Lakartidningen; 1993 Nov; 90(45):3938-40. PubMed ID: 8231562
    [No Abstract]   [Full Text] [Related]  

  • 35. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
    Parmigiani S
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical use of single-dose surfactant TA therapy for premature infants with severe respiratory distress syndrome.
    Deng HH; Kuo MC; Chung KH; Hsu HH; Lin ST
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(6):408-16. PubMed ID: 1306925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic surfactant. Giving premature infants a better chance for survival.
    Paynton A
    Nursing; 1991 Mar; 21(3):64. PubMed ID: 2002933
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Substitutive therapy with surfactants in premature infants with respiratory distress syndrome].
    Liberatore A; Carrera G; Calciolari G; Coccia C; Coppalini B; Fulconis F; Moro G; Scimone F; Villa G; Minoli I
    Ann Osp Maria Vittoria Torino; 1987-1988; 30():28-35. PubMed ID: 3334194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant replacement therapy: clinical and experimental studies.
    Vidyasagar D; Raju TN; Shimada S; Maeta H
    Clin Perinatol; 1987 Sep; 14(3):713-36. PubMed ID: 3311546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.